Provision of Lateral Flow testing devices for the detection of COVID-19 viral antigens

Concepts

• diagnostic kits
• ukhsa
• provision of lateral flow testing devices
• detection of covid-19
• viral antigens
• time periods
• omicron outbreak
• significant risk
• urgency
• negotiated procedure

Location

United Kingdom:

Description

The Omicron outbreak and its high transmissibility has however led to an urgent and unforeseeable surge in demand for LFTs. Due to this urgency, UKHSA is unable to comply with the time periods required for a further competitive tender (whether under the DPS or otherwise), as any delay will risk the current stock of competitively-procured LFTs being exhausted thereby introducing a significant risk to public health. UKHSA has therefore used the negotiated procedure without prior publication under Regulation 32(2)(c) of the Public Contracts Regulations 2015 to award a contract to Tanner Pharma UK LImited on 29 December 2021 for £169,000,000.

Total Quantity or Scope

The Omicron outbreak and its high transmissibility has however led to an urgent and unforeseeable surge in demand for LFTs. Due to this urgency, UKHSA is unable to comply with the time periods required for a further competitive tender (whether under the DPS or otherwise), as any delay will risk the current stock of competitively-procured LFTs being exhausted thereby introducing a significant risk to public health. UKHSA has therefore used the negotiated procedure without prior publication under Regulation 32(2)(c) of the Public Contracts Regulations 2015 to award a contract to Tanner Pharma UK LImited on 29 December 2021 for £169,000,000.

Award Detail

Award Criteria

CPV Codes

• 33141625 - Diagnostic kits

Legal Justification

Mass testing using lateral flow testing kits (LFTs) for the detection of Covid-19 viral antigens has become a key part of protecting the economy and saving lives during the Covid-19 pandemic. UKHSA has ensured the supply of LFTs by implementing a Dynamic Purchasing System (as advertised in a contract notice on the Find a Tender Service with reference C22033 on 5 March 2021) and procuring LFTs competitively through that DPS. A further competitive tender through the DPS is currently in progress. The Omicron outbreak and its high transmissibility has however led to an urgent and unforeseeable surge in demand for LFTs. Due to this urgency, UKHSA is unable to comply with the time periods required for a further competitive tender (whether under the DPS or otherwise), as any delay will risk the current stock of competitively-procured LFTs being exhausted thereby introducing a significant risk to public health. UKHSA has therefore used the negotiated procedure without prior publication under Regulation 32(2)(c) of the Public Contracts Regulations 2015 to award a contract to Tanner Pharma UK LImited on 29 December 2021 for £169,000,000.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **